296 related articles for article (PubMed ID: 30652677)
1. Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):159-166. PubMed ID: 30652677
[TBL] [Abstract][Full Text] [Related]
2. Increase of circulating memory B cells after glucocorticoid-induced remission identifies patients at risk of IgG4-related disease relapse.
Lanzillotta M; Della-Torre E; Milani R; Bozzolo E; Bozzalla-Cassione E; Rovati L; Arcidiacono PG; Partelli S; Falconi M; Ciceri F; Dagna L
Arthritis Res Ther; 2018 Oct; 20(1):222. PubMed ID: 30285841
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
[TBL] [Abstract][Full Text] [Related]
4. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.
Mattoo H; Mahajan VS; Della-Torre E; Sekigami Y; Carruthers M; Wallace ZS; Deshpande V; Stone JH; Pillai S
J Allergy Clin Immunol; 2014 Sep; 134(3):679-87. PubMed ID: 24815737
[TBL] [Abstract][Full Text] [Related]
5. A CD8α- Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment.
Della-Torre E; Bozzalla-Cassione E; Sciorati C; Ruggiero E; Lanzillotta M; Bonfiglio S; Mattoo H; Perugino CA; Bozzolo E; Rovati L; Arcidiacono PG; Balzano G; Lazarevic D; Bonini C; Falconi M; Stone JH; Dagna L; Pillai S; Manfredi AA
Arthritis Rheumatol; 2018 Jul; 70(7):1133-1143. PubMed ID: 29499100
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P; Gong Y; Liu Z; Liu Y; Lin W; Li J; Wang M; Liu X; Fei Y; Chen H; Peng L; Li J; Zhou J; Shi Q; Zhang X; Shen M; Zeng X; Zhang F; Li Y; Zhao Y; Zhang W
Int J Rheum Dis; 2019 Aug; 22(8):1479-1488. PubMed ID: 31245907
[TBL] [Abstract][Full Text] [Related]
7. B lymphocytes directly contribute to tissue fibrosis in patients with IgG
Della-Torre E; Rigamonti E; Perugino C; Baghai-Sain S; Sun N; Kaneko N; Maehara T; Rovati L; Ponzoni M; Milani R; Lanzillotta M; Mahajan V; Mattoo H; Molineris I; Deshpande V; Stone JH; Falconi M; Manfredi AA; Pillai S
J Allergy Clin Immunol; 2020 Mar; 145(3):968-981.e14. PubMed ID: 31319101
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease.
Chen Y; Lin W; Yang H; Wang M; Zhang P; Feng R; Chen H; Peng L; Zhang X; Zhao Y; Zeng X; Zhang F; Zhang W; Lipsky PE
Arthritis Rheumatol; 2018 Nov; 70(11):1853-1865. PubMed ID: 29781221
[TBL] [Abstract][Full Text] [Related]
9. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease.
Akiyama M; Yasuoka H; Yamaoka K; Suzuki K; Kaneko Y; Kondo H; Kassai Y; Koga K; Miyazaki T; Morita R; Yoshimura A; Takeuchi T
Arthritis Res Ther; 2016 Jul; 18():167. PubMed ID: 27411315
[TBL] [Abstract][Full Text] [Related]
10. Increased Circulating Th1 and Tfh1 Cell Numbers Are Associated with Disease Activity in Glucocorticoid-Treated Patients with IgG4-Related Disease.
Xia C; Liu C; Liu Y; Long Y; Xu L; Liu C
J Immunol Res; 2020; 2020():3757015. PubMed ID: 33313326
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage.
Zhang P; Zhang Y; Pan M; Liu Z; Li J; Peng L; Zhou J; Hu C; Liu S; Zeng X; Ge W; Zhang W
J Autoimmun; 2021 Aug; 122():102650. PubMed ID: 34107438
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.
Fernández-Codina A; Pinilla B; Pinal-Fernández I; López C; Fraile-Rodríguez G; Fonseca-Aizpuru E; Carballo I; Brito-Zerón P; Feijóo-Massó C; López-Dupla M; Cid MC; Martínez-Valle F; ; ;
Joint Bone Spine; 2018 Dec; 85(6):721-726. PubMed ID: 29452298
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of plasmablasts in predicting disease relapse in patients with IgG4-related disease.
Wang Y; Zhao Z; Gao D; Wang H; Liao S; Luo G; Ji X; Li Y; Wang X; Zhao Y; Li K; Zhang J; Jin J; Zhang Y; Zhu J; Zhang J; Huang F
Clin Rheumatol; 2023 Jan; 42(1):135-143. PubMed ID: 36074221
[TBL] [Abstract][Full Text] [Related]
14. B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives.
Lanzillotta M; Stone JH; Della-Torre E
Mod Rheumatol; 2023 Mar; 33(2):258-265. PubMed ID: 35983918
[TBL] [Abstract][Full Text] [Related]
15. Examination of the Level of Circulating Plasmablasts and Their Characteristics as Diagnostic Tools for Immunoglobulin G4-related Disease.
Tartakover Matalon S; Rabinowicz N; Carmi O; Zitman-Gal T; Drucker L; Levy Y
Isr Med Assoc J; 2024 Jun; 26(6):369-375. PubMed ID: 38884310
[TBL] [Abstract][Full Text] [Related]
16. Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease.
Li J; Liu Z; Zhang P; Lin W; Lu H; Peng Y; Peng L; Zhou J; Wang M; Chen H; Zhao L; Wang L; Qin C; Hu C; Zeng X; Zhao Y; Fei Y; Zhang W
Front Immunol; 2021; 12():747076. PubMed ID: 34603334
[TBL] [Abstract][Full Text] [Related]
17. New insights into immune cells cross-talk during IgG4-related disease.
Touzani F; Pozdzik A
Clin Immunol; 2019 Jan; 198():1-10. PubMed ID: 30419354
[TBL] [Abstract][Full Text] [Related]
18. Development of targeted therapies in IgG4-related disease.
Nakayamada S; Tanaka Y
Mod Rheumatol; 2023 Mar; 33(2):266-270. PubMed ID: 35983919
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.
Berti A; Della-Torre E; Gallivanone F; Canevari C; Milani R; Lanzillotta M; Campochiaro C; Ramirez GA; Bozzalla Cassione E; Bozzolo E; Pedica F; Castiglioni I; Arcidiacono PG; Balzano G; Falconi M; Gianolli L; Dagna L
Rheumatology (Oxford); 2017 Dec; 56(12):2084-2092. PubMed ID: 28977663
[TBL] [Abstract][Full Text] [Related]
20. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease.
Della-Torre E; Feeney E; Deshpande V; Mattoo H; Mahajan V; Kulikova M; Wallace ZS; Carruthers M; Chung RT; Pillai S; Stone JH
Ann Rheum Dis; 2015 Dec; 74(12):2236-43. PubMed ID: 25143523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
